BindingDB logo
myBDB logout

74 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28131094 66 New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluation.EBI Universities of Lille
26390077 42 Tactical Approaches to Interconverting GPCR Agonists and Antagonists.EBI University of Minnesota
26820449 84 Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.EBI Universit£
26785296 32 Synthesis of 2-arylfuro[3,2-b]pyridines: Effect of the C2-aryl group on melatoninergic activity.EBI Universit£
26367450 4 New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization.EBI Iqm-Csic
26023814 79 Novel N-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential.EBI Iqm-Csic
25232966 52 Efficient synthesis of hexahydroindenopyridines and their potential as melatoninergic ligands.EBI Universidad De Valencia
24228714 64 MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.EBI The German University In Cairo
23228808 22 Development of substituted N-[3-(3-methoxylphenyl)propyl] amides as MT(2)-selective melatonin agonists: improving metabolic stability.EBI Hong Kong University of Science and Technology
23265885 30 Synthesis of new N-(arylcyclopropyl)acetamides and N-(arylvinyl)acetamides as conformationally-restricted ligands for melatonin receptors.EBI Paris-Sud University
21775151 22 Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide: synthesis, binding affinity and intrinsic activity for MT(1) and MT(2) melatonin receptors.EBI Universit£
20674373 84 Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.EBI Universit£
20444610 71 Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.EBI University of Lille
10737738 78 Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.EBI King'S College London
21764185 12 Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands.EBI Universit£
21568291 30 Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1/MT2) ligands.EBI Takeda Pharmaceutical
21392858 28 Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.EBI University of Lille
21473625 42 1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT2-selective agonists.EBI Takeda Pharmaceutical
21377769 30 Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.EBI University of Lille
21420861 50 Design and synthesis of 1-(2-alkanamidoethyl)-6-methoxy-7-azaindole derivatives as potent melatonin agonists.EBI Universit£
20621473 56 Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists.EBI Merck Research Laboratories
20227878 40 Synthesis of substituted N-[3-(3-methoxyphenyl)propyl] amides as highly potent MT(2)-selective melatonin ligands.EBI Hong Kong University of Science and Technology
19473848 7 Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.EBI University of W£Rzburg
 26 The development of a charged melatonin receptor ligandEBI TBA
 12 Synthesis and receptor binding studies of quinolinic derivatives as melatonin receptor ligandsEBI TBA
19193160 42 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.EBI University of WüRzburg
18778943 53 Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.EBI University of Lille 2
18657980 14 Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands.EBI University of WüRzburg
18372181 32 Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.EBI Université
17481904 24 Synthesis and biological activity of new melatonin dimeric derivatives.EBI Università
16759094 70 Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.EBI University of Athens
15713384 28 (R)-2-(4-Phenylbutyl)dihydrobenzofuran derivatives as melatoninergic agents.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
15501061 51 Tetrahydroisoquinoline derivatives as melatonin MT2 receptor antagonists.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
15380218 40 N-[2-[2-(4-Phenylbutyl)benzofuran-4-yl]cyclopropylmethyl]acetamide: an orally bioavailable melatonin receptor agonist.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
15203165 80 Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
15013015 76 4-Substituted anilides as selective melatonin MT2 receptor agonists.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
14980664 48 Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
14643330 40 Heterocyclic aminopyrrolidine derivatives as melatoninergic agents.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
12646022 22 Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.EBI Université
12643943 43 Indanyl piperazines as melatonergic MT2 selective agents.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
12213063 4 Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists.EBI Takeda Chemical Industries
12061881 94 Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands.EBI Institut De Chimie Pharmaceutique Albert Lespagnol
11960497 36 Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).EBI Institut De Chimie Pharmaceutique Albert Lespagnol
11063602 84 Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors.EBI Paris-Sud University
31298539 18 Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68).EBI Icahn School of Medicine At Mount Sinai
31204226 4 Polybenzyls from Gastrodia elata, their agonistic effects on melatonin receptors and structure-activity relationships.EBI Chinese Academy of Sciences
9435890 7 Development of a high-affinity ligand that binds irreversibly to Mel1b melatonin receptors.EBI Duquesne University
31727472 30 Indole-based melatonin analogues: Synthetic approaches and biological activity.EBI Nantong University
24900790 8 Original Design of Fluorescent Ligands by Fusing BODIPY and Melatonin Neurohormone.EBI Universit£
18052314 32 N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.EBI Universit£
17459711 55 7-Substituted-melatonin and 7-substituted-1-methylmelatonin analogues: effect of substituents on potency and binding affinity.EBI University College London
15943478 22 Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.EBI Universit£
15293992 26 Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.EBI Universit£
12672242 8 Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.EBI Universit£
11520198 54 2-N-acylaminoalkylindoles: design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists.EBI Universit£
30015074 2 Synthesis and biological evaluation of magnolol derivatives as melatonergic receptor agonists with potential use in depression.EBI Chinese Academy of Sciences
29102176 135 Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MTEBI Univ. Lille
30126274 44 Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit.EBI Universit£
29595267 39 Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands.EBI Universit£
27894776 26 Design, synthesis, cyclooxygenase inhibition and biological evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing amino/methanesulfonyl pharmacophore.BDB Beni-Suef University
26398140 54 1-(4-Methane(amino)sulfonylphenyl)-3-(4-substituted-phenyl)-5-(4-trifluoromethylphenyl)-1H-2-pyrazolines/pyrazoles as potential anti-inflammatory agents.BDB Beni-Suef University